Perform rapid and non-destructive identification of pharmaceutical raw materials, excipients and packaging materials, comply with FDA 21CFR part11 and other relevant regulations, and provide 3Q support.
Rapid Response: Identification can be completed within seconds.
No Sampling Required: No need to transfer raw materials to the sampling room, avoid sample contamination.
Through-Packaging Detection: Capable of detecting directly through glass, woven bags, plastic, and other packaging materials.
Compact and Lightweight: Portable and flexible for use in various on-site locations such as warehouses,preparation rooms, and production workshops.
Accurate Identification: Utilizes advanced machine learning algorithms, ensuring high accuracy.
JINSP DI series pharmaceutical rapid identification device can perform 100% batch-by-batch inspection of raw materials and packaging materials. It is capable of quickly identifying raw materials in various on-site locations such as warehouses, preparation rooms, and production workshops,assisting pharmaceutical companies in expediting material release. The DI series products comply with relevant regulations such as FDA 21CFR part11 and GMP. JNSP will provide comprehensive technical support services in areas including installation, validation, and 3Q certification.
Wide detection range, capable of identifying both chemical and biological drugs RS1000DI & RS1500DI
• Chemical raw materials: aspirin, acetaminophen, folic acid, nicotinamide, etc.
• Pharmaceutical excipients: salts, alkalis, sugars, esters, alcohols, phenols, etc.
• Common packaging materials: polyethylene, polypropylene, polycarbonate, ethylene-vinyl acetate copolymer.
RS 1500DI Overcomes Fluorescence Interference with Enhanced Detection Capabilities.
Biochemical raw materials: amino acids and their derivatives, enzymes and coenzymes, proteins.
• Dying additives: carmine, carotene, curcumin, chlorophyll, etc.
• Other polymer excipients: gelatin, microcrystalline cellulose, etc.
RS1000DI and RS1500DI meet the requirements of FDA 21CFR part11 and GMP Regulations.
